Global Assessment of Functioning Scale

Original Editor - Rotimi Alao

Top Contributors - Rotimi Alao, Uchechukwu Chukwuemeka, Momina Khalid, Vidya Acharya and Alexandra Stead

Introduction

The Global Assessment of Functioning (GAF) is a clinician-rated scale that measures an individual's psychological, social, and occupational health on a numeric continuum from 1 to 100. By evaluating how effectively a person manages daily demands, the scale captures a snapshot of their mental health, ranging from severe psychopathology to superior functioning.

Formerly included in psychiatric evaluation as Axis V in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), the GAF was eventually replaced in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-5) by the World Health Organization Disability Assessment Schedule (WHODAS) 2.0. Despite its formal removal from the manual, it remains a common tool for monitoring clinical progress, assessing treatment outcomes, and conducting psychiatric research.

Objectives

The GAF provides a global measure of psychiatric severity across three dimensions: psychological (symptoms/cognition), social (relationships), and occupational (work/school). It is used to establish baselines, monitor treatment progress, and assist in discharge planning. Essentially, the GAF ignores physical or environmental limitations, focusing strictly on mental health-related functioning.

Intended Population

The Global Assessment of Functioning is primarily intended for adult psychiatric patients across all diagnostic categories to evaluate the impact of mental health on their psychological, social, and occupational daily living.

Method of use

The scale is a clinician-rated tool usually completed in under five minutes. Practitioners/clinicians assign a score based on interviews, medical records, and reports from secondary informants. The final score typically reflects the patient's worst functioning in any of the three domains over a specific period ( typically the past month).

The DSM-IV-TR (American Psychiatric Association, 2000), referenced in Aas is the source of the following scale and scoring descriptors outlined below:

The Scale and Scoring

Score Range	Descriptor	Clinical Features
91–100	Superior Functioning	No symptoms. Superior functioning across a wide range of activities; life problems never seem to get out of hand; sought out by others due to positive qualities.
81–90	Minimal Symptoms	Absent or minimal symptoms (e.g., mild anxiety before an exam); good functioning in all areas; socially effective; generally satisfied with life; no more than everyday problems or concerns.
71–80	Transient Symptoms	If symptoms are present, they are transient and expected reactions to psychosocial stressors (e.g., difficulty concentrating after a family argument); no more than slight impairment in social, occupational, or school functioning.
61–70	Mild Symptoms	Some mild symptoms (e.g., depressed mood, mild insomnia) OR some difficulty in social, occupational, or school functioning, but generally functioning well with some meaningful interpersonal relationships.
51–60	Moderate Symptoms	Moderate symptoms (e.g., flat affect, circumstantial speech, occasional panic attacks) OR moderate difficulty in social, occupational, or school functioning (e.g., few friends, conflicts with peers or co-workers).
41–50	Serious Symptoms	Serious symptoms (e.g., suicidal ideation, severe obsessional rituals, frequent shoplifting) OR any serious impairment in social, occupational, or school functioning (e.g., no friends, unable to keep a job).
31–40	Major Impairment	Some impairment in reality testing or communication (e.g., speech is at times illogical, obscure, or irrelevant) OR major impairment in several areas (work/school, family relations, judgment, thinking, or mood).
21–30	Serious Impairment	Behaviour considerably influenced by delusions or hallucinations OR serious impairment in communication or judgment (e.g., sometimes incoherent, acts grossly inappropriately, suicidal preoccupation) OR inability to function in almost all areas.
11–20	Danger to Self/Others	Some danger of hurting self or others (e.g., suicide attempts without clear expectation of death, frequently violent, manic excitement) OR occasionally fails to maintain minimal personal hygiene OR gross impairment in communication.
1–10	Persistent Danger	Persistent danger of severely hurting self or others (e.g., recurrent violence) OR persistent inability to maintain minimal personal hygiene OR serious suicidal act with clear expectation of death.
0	Inadequate Information	Not enough information available to rate.

Interpretation

Clinicians select the lowest score that matches the patient's presentation. While a single global score is standard, some systems use dual-scoring (GAF-S for symptoms and GAF-F for functioning) to increase sensitivity. In clinical practice, a shift of 10 points or more is generally required to indicate a meaningful change in a patient's status.

As a general guide:

• 91–100: Healthy, high-functioning individuals
• 71–90: Mild problems; generally good functioning
• 51–70: Moderate difficulties; functioning compromised
• 31–50: Serious impairment; significant disruption in daily life
• 1–30: Severe to very severe impairment; possible inpatient care required

Evidence

Reliability

The GAF’s inter-rater reliability often fluctuates based on clinician training, typically performing better in research settings than in routine practice. The modified GAF (Hall, 1995) demonstrated an intraclass correlation coefficient of 0.81, compared to 0.62 for the original version. Satisfactory inter-rater reliability was obtained in severely mentally ill populations following a brief training session. The Mental Illness Research, Education, and Clinical Centers (MIRECC) GAF subscales (occupational, social, symptom) exhibited very high levels of internal reliability.

While the original scale shows moderate consistency, modified versions and targeted training sessions significantly enhance reliability, with some subscales achieving very high internal consistency (Cronbach's α = 0.98) in a study conducted in outpatient psychiatric clinic populations.

Validity

The scale demonstrates strong construct and concurrent validity, correlating well with tools like the Functional Assessment Rating Scale (FARS) and the Zung Depression Scale (r = −0.73). However, its content validity is sometimes criticised in everyday clinical use, as scores frequently skew toward reflecting immediate symptom severity rather than distinct social or occupational functioning.

Sensitivity to Change

The GAF is sensitive to clinical shifts, particularly when correlated with the Positive and Negative Syndrome Scale (PANSS). Specialised versions, such as the MIRECC GAF, have proven effective at predicting long-term social and occupational outcomes, though recent 2024 data suggests the WHODAS may offer superior responsiveness in specific pediatric domains.

However, a fundamental limitation compromises the GAF's responsiveness in routine clinical practice. The GAF's validity is diminished when symptom severity and actual functioning are contradictory, which is a common clinical scenario. This is because the GAF combines symptom severity and functional impairment into a single score and instructs raters to record the lower of the two. In fact, it has been repeatedly demonstrated that clinician-assigned GAF scores have a stronger correlation with symptom ratings than with social or occupational functioning, indicating that the scale tends to measure changes in symptoms rather than actual functional changes. The GAF was removed from the DSM-5 in 2013 because the DSM-5 Task Force determined that its limitations outweighed its value as a worldwide measure of impairment, partly due to this confusion of symptoms and disability.